Product Information
OLOPATADINE HCL 0.1% EYE DROP is a generic product labeled by Rising Pharma Holdings Inc., priced at $1.2677 per ML under NDC 16571088205. Its NADAC has been published 52 times since Aug 27, 2025.
FDA first approved this application on Mar 21, 2018.
Strength
1 mg/mL
Manufacturer
Rising Pharma Holdings Inc.NDC
16571088205
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
OLOPATADINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204392FDA Approved
3/21/2018
On Market Since
5/1/2025
Pharmacological Classes
Price Statistics
The NADAC for OLOPATADINE HCL 0.1% EYE DROP has been published 52 times since Aug 27, 2025, and over the history we have for it it has declined 3.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2677 per ML |
|---|---|
| All-time high | $1.3149 (Sep 10, 2025) |
| All-time low | $1.2029 (Feb 18, 2026) |
| 52-week high | $1.3149 |
| 52-week low | $1.2029 |
| Median price | $1.2286 |
| Average price | $1.2386 |
| Largest weekly change | -3.1% (Sep 17, 2025) |
| Weeks tracked | 52 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the olopatadine hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OLOPATADINE HCL 0.1% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for OLOPATADINE HCL 0.1% EYE DROP, manufactured by Rising Pharma Holdings Inc., is $1.2677 per ML (NDC 16571088205), effective Aug 19, 2026.
How has the price of OLOPATADINE HCL 0.1% EYE DROP changed over time?
Over the history we have for it, the NADAC for OLOPATADINE HCL 0.1% EYE DROP has declined 3.6%. It has been tracked across 52 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for OLOPATADINE HCL 0.1% EYE DROP?
Since Aug 27, 2025, the NADAC for OLOPATADINE HCL 0.1% EYE DROP has ranged from a low of $1.2029 (Feb 18, 2026) to a high of $1.3149 (Sep 10, 2025), with a median of $1.2286 per ML.
Are there cheaper alternatives to OLOPATADINE HCL 0.1% EYE DROP?
No other NADAC-published product currently shares the active ingredient and strength of OLOPATADINE HCL 0.1% EYE DROP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OLOPATADINE HCL 0.1% EYE DROP?
OLOPATADINE HCL 0.1% EYE DROP (NDC 16571088205) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.